Resolvin E1 attenuates doxorubicin-induced cardiac fibroblast senescence: A key role for IL-1β

Autor: Jenaro A. Espitia-Corredor, Licia Shamoon, Francisco Olivares-Silva, Constanza Rimassa-Taré, Claudia Muñoz-Rodríguez, Claudio Espinoza-Pérez, Carlos F. Sánchez-Ferrer, Concepción Peiró, Guillermo Díaz-Araya
Rok vydání: 2022
Předmět:
Zdroj: Biblos-e Archivo. Repositorio Institucional de la UAM
instname
ISSN: 0925-4439
DOI: 10.1016/j.bbadis.2022.166525
Popis: Cardiac fibroblasts (CFs) undergo senescence in reaction to different stressors, leading to a poor prognosis of cardiac disease. Doxorubicin (Doxo) is an antineoplastic drug with strong cardiotoxic effects, which induces IL-1β secretion and thus, triggers a potent pro-inflammatory response. Doxo induces CFs senescence; however, the mechanisms are not fully understood. Different pharmacological strategies have been used to eliminate senescent cells by inducing their apoptosis or modifying their secretome. However, Resolvin E1 (RvE1), a lipid derivative resolutive mediator with potent anti-inflammatory effects has not been used before to prevent CFs senescence. CFs were isolated from adult male C57BL/6J mice and subsequently stimulated with Doxo, in the presence or absence of RvE1. Senescence-associated β-galactosidase activity (SA-β-gal), γ-H2A.X, p53, p21, and senescence-associated secretory phenotype (SASP) were evaluated. The involvement of the NLRP3 inflammasome/interleukin-1 receptor (IL-1R) signaling pathway on CFs senescence was studied using an NLRP3 inhibitor (MCC950) and an endogenous IL-1R antagonist (IR1A). Doxo is able to trigger CFs senescence, as evidenced by an increase of γ-H2A.X, p53, p21, and SA-β-gal, and changes in the SASP profile. These Doxo effects were prevented by RvE1. Doxo triggers IL-1β secretion, which was dependent on NLRP3 activation. Doxo-induced CFs senescence was partially blocked by MCC950 and IR1A. In addition, IL-1β also triggered CFs senescence, as evidenced by the increase of γ-H2A.X, p53, p21, SA-β-gal activity, and SASP. All these effects were also prevented by RvE1 treatment. Conclusion: These data show the anti-senescent role of RvE1 in Doxo-induced CFs senescence, which could be mediated by reducing IL-1β secretion.
This study was supported by PID2020-115590RB-100/AEI/ 10.13039/501100011033 and FONDECYT 1210627 to C.P., C.F.S.F., and G.D.A., respectively. L.S. and J.A.E.C. are the recipients of FPI Universidad Autonoma ´ de Madrid (SFPI/2020-00053) and Beca Doctorado Nacional Ano ˜ 2017 ANID (21170233) fellowships, respectively
Databáze: OpenAIRE
Externí odkaz: